Back to Directory
NanoRegMed
Greater London
Founded 2016
Graphene nanocomposites and biomaterials for regenerative medicine research
NanoRegMed is a London biotechnology company developing graphene-based polymers and nanocomposites for regenerative medicine and industrial applications.
Its Hastalex and BioHastalex materials have tunable properties for potential tissue repair and implant applications. The company also supplies reduced and functionalised graphene oxide for research.
Based at the London BioScience Innovation Centre, NanoRegMed offers materials licensing and collaborative research services. Clinical approval for implant applications is not established.